{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:06:05Z","timestamp":1782295565756,"version":"3.54.5"},"reference-count":12,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Summary at a Glance<\/jats:title><jats:p>This retrospective study analyzed the association between intravenous abuse of extended\u2010release oxymorphine and acute kidney injury. The prevalence of acute kidney injury was 47.8%. Individuals with established chronic kidney disease had a worse outcome. Although previously reported as an association, no cases of thrombotic microangiopathy were reported in this cohort.<\/jats:p>","DOI":"10.1111\/nep.13153","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T13:42:37Z","timestamp":1502545357000},"page":"921-926","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute kidney injury is common with intravenous abuse of extended\u2010release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging"],"prefix":"10.1111","volume":"23","author":[{"given":"Alex K","family":"Bonnecaze","sequence":"first","affiliation":[{"name":"Department of Internal Medicine Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Dharod","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section on General Internal Medicine Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section on Nephrology Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter John","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"},{"name":"Department of Internal Medicine, Section on Pulmonary, Critical Care, Allergy, and Immunological Diseases Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"},{"name":"Department of Anesthesia, Section on Hematology and Oncology Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"},{"name":"Department of Internal Medicine, Section on Critical Care Medicine Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-005-0917-1"},{"key":"e_1_2_7_3_1","first-page":"324","article-title":"Oxymorphone extended\u2010release tablets (Opana ER) for the management of chronic pain: A practical review for pharmacists","volume":"35","author":"Craig DS","year":"2010","journal-title":"P&T"},{"key":"e_1_2_7_4_1","unstructured":"Prevention CfDCa.National Vital Statistics System Mortality Data 2015.Available from URL:http:\/\/www.cdc.gov\/nchs\/deaths.htm. Access Date: January 27th 2017"},{"key":"e_1_2_7_5_1","first-page":"563","article-title":"Vital signs: Variation among states in prescribing of opioid pain relievers and benzodiazepines \u2013 United States, 2012","volume":"63","author":"Paulozzi LJ","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"e_1_2_7_6_1","first-page":"1","article-title":"Thrombotic thrombocytopenic purpura (TTP)\u2010like illness associated with intravenous Opana ER abuse\u2013Tennessee, 2012","volume":"62","author":"(CDC) CfDCaP","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23720"},{"key":"e_1_2_7_8_1","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Group KDIGOKAKIW","year":"2012","journal-title":"Kindey Int. Suppl."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp053024"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2012.01767.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood.V126.23.3521.3521","article-title":"A mechanistic investigation of the TTP\u2010like state associated with intravenous abuse of Opana \u00ae ER","volume":"126","author":"Hunt R","year":"2015","journal-title":"Blood"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.01125"},{"key":"e_1_2_7_13_1","unstructured":"Purdue Pharma.Oxycontin Full Prescribing Information.2016December. [Cited 6 Oct 2017.] Available from URL:http:\/\/app.purduepharma.com\/xmlpublishing\/pi.aspx?id=o"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnep.13153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.13153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/nep.13153","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.13153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T19:01:18Z","timestamp":1694286078000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nep.13153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/nep.13153"],"URL":"https:\/\/doi.org\/10.1111\/nep.13153","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"2017-08-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}